INOVIO Pharmaceuticals Inc (NASDAQ: INO) is having a horrible start to the trading session this morning after the company announced that the United States government will no longer fund its COVID-19 clinical activities. Here’s what’s going on: US Pulls INOVIO Funding As mentioned above, INOVIO Pharmaceuticals is falling more than 30% in the market this … Read more
Inovio Pharmaceuticals Inc (NASDAQ: INO) is having an overwhelmingly strong start to the trading session in the pre-market hours after releasing new clinical data. The data came from the company’s PENNVAX®-GP, an HIV vaccine that’s showing some promising results. Of course, the clinical update led to excitement among investors, sending the stock on a run for … Read more
Inovio Pharmaceuticals Inc (NASDAQ: INO) is having an overwhelmingly strong start to the trading session this morning after announcing that it has entered into a partnership that includes funding in the amount of $56 million. As you could imagine, the news led to excitement among investors, sending the stock screaming for the top. Today, we’ll … Read more
Inovio Pharmaceuticals Inc (NASDAQ: INO) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that it has closed a license and collaboration agreement with ApolloBio. Of course, as soon as investors heard the news, the stock started to find its way upward. Today, we’ll talk about … Read more
Inovio Pharmaceuticals Inc (NASDAQ: INO) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company released a key clinical update late yesterday. Today, we’ll talk about the update, what we’re seeing from the stock, and what we’ll be watching for with regard to INO ahead. INO Releases Clinical … Read more
Inovio Pharmaceuticals Inc (NASDAQ: INO) is having a relatively strong start to the trading session this morning, and for good reason. The company announced a license and collaboration agreement that’s leading to excitement among investors. Today, we’ll talk about the agreement, what we’re seeing from the stock as a result, and what we’ll be watching … Read more
Inovio Pharmaceuticals Inc (NASDAQ: INO) is having a relatively strong start to the trading session this morning after the company reported positive data surrounding a key vaccine. Of course, our partners at Trade Ideas were the first to alert us to the gains. At the moment (10:09), INO is trading at $6.58 per share after … Read more
Inovio Pharmaceuticals Inc (NASDAQ: INO) is off to an incredibly strong day in the market today, and for good reason. The company released results with regard to its HIV Vaccine, showing a nearly 100% immune response rate. Of course, this led to excitement among investors, pushing the stock upward and prompting our partners at Trade … Read more
Zed’s dead, baby, Zed’s dead. And for the most part, so are those small-cap investor roadshows, who’s sponsor fill their prospective clients with the promise of analyst exposure and investor interest, only to find their stocks falling flat, despite the five digit expense paid to these so-called exposure specialists. Need first-hand proof, look at the … Read more
Inovio Pharmaceuticals Inc (NASDAQ: INO) Inovio Pharmaceuticals is spiking at the market open, up 6% after news was released that INO’s DNA based vaccine has induced a robust immune responses in the first ever in-human studies to combat the Zika virus. Our friends at Trade Ideas provided us a real-time alert to the news, causing … Read more